| Previous Close | 116.22 |
| Open | 115.85 |
| Bid | 112.55 x 800 |
| Ask | 116.64 x 700 |
| Day's Range | 114.51 - 116.05 |
| 52 Week Range | 102.07 - 121.24 |
| Volume | 126 |
| Avg. Volume | 2,090,617 |
| Net Assets | 36.9B |
| NAV | 117.20 |
| PE Ratio (TTM) | -59.62 |
| Yield | 2.21% |
| YTD Return | 5.80% |
| Beta (3y) | 0.98 |
| Expense Ratio (net) | 0.20% |
| Inception Date | 2000-05-22 |
- Market Realist•2 days ago
Dentsply Sirona’s Technologies Segment Sales Declined in 2Q17
In 2Q17, Dentsply Sirona’s (XRAY) Technologies business contributed ~44% to the company’s total revenues and registered sales of ~$439 million.
- Market Realist•3 days ago
What Kyprolis Could Do for Amgen’s Revenue Growth
In 2Q17, Amgen’s (AMGN) Kyprolis generated revenues of ~$211 million, which reflected ~23% growth on a YoY (year-over-year) basis and ~11% growth QoQ (quarter-over-quarter). In 2Q17, Kyprolis witnessed ...
- Zacks•8 days ago
Time to Short U.S. Equities with ETFs?
Risk aversion in U.S. equities is triggered on overvaluation and geopolitical concerns. How to profit via ETFs?
